Anlotinib Hydrochloride plus Docetaxel
Sponsors
The Affiliated Hospital of Qingdao University, Qilu Hospital of Shandong University, Shandong Cancer Hospital and Institute
Conditions
Non Small Cell Lung Cancer
Phase 2
Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034）
NCT03735264
Start: 2018-11-15End: 2020-10-15Target: 46Updated: 2018-11-08
Anlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer
NCT03750916
Start: 2018-11-30End: 2020-11-30Target: 46Updated: 2018-11-26
A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer Patients
NCT04619563
Start: 2020-11-04End: 2022-10-31Target: 42Updated: 2020-11-18
A Trial of Anlotinib Combined With Docetaxel in Patients With Wild-type Advanced Non-squamous Non Small Cell Lung Cancer
NCT04619537
Start: 2020-10-08End: 2022-10-31Target: 42Updated: 2020-11-18